期刊文献+

原发性肝癌的非手术治疗进展 被引量:1

The development of non-surgical therapy for primary liver carcinoma
下载PDF
导出
摘要 尽管手术切除及肝移植治疗可以明显延长肝癌病人的生存期,但是由于疾病发现时多属晚期,无法行手术治疗。因此,非手术治疗在原发性肝癌的治疗中起着举足轻重的作用。近年来,原发性肝癌的介入治疗、放疗、中药治疗、物理治疗等得到了不断的发展。 Although surgical therapies such as surgical resection and liver transplantation can effectively prolong the survival time of the patients with primary liver carcinoma, the late diagnosis of the disease deprives the patients of the chances of taking surgical therapies. Therefore, the non-surgical therapies for primary liver carcinoma play a rather indispensable role in China. Recently, the intra-arterial therapy, the radiation therapy, the TCM therapy, and other therapies have all had their enhancement.
出处 《世界肿瘤杂志》 2007年第2期133-136,共4页 Tumour Journal of the World
关键词 原发性肝癌 非手术治疗 Primary liver carcinoma non-surgical therapy
  • 相关文献

同被引文献10

  • 1] Li L C, Okino S T, Zhao H, et al. Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci USA, 2006,103(46) :17337-17342.
  • 2Hakkarainen T, Rajecki M, Sarparanta M, et al. Targeted radiotherapy for prostate cancer with an oncolytic adenovirus coding for human sodium iodide symporter. Clin Cancer Res, 2009, 15 (17) :5396-5403.
  • 3Haddad D, Zanzonico P B, Carlin S, et al. A vaccinia virus encoding the human sodium iodide symporter facilitates long-term image monitoring of virotherapy and targeted radiotherapy of pancreatic cancer. J Nucl Med,2012,53 (12) : 1933-1942.
  • 4Griinwald G K, Klutz K, Willhauck M J, et al. Sodium iodide symporter (NIS) - mediated radiovirotherapy of hepatocellular cancer using a conditionally replicating adenovirus. Geue Ther,2013, 20 (6) :625-633.
  • 5Haddad D, Chen C H, Carlin S, et al. Imaging characteristics, tissue distribution, and spread of a novel oncolytic vaccinia virus carrying the human sodium iodide symporter. PLoS One, 2012, 7 (8) : e41647.
  • 6Faivre J, Clerc J, Gorolami R, et al. Long-termradioiodine retention and regression of liver cancer after sodium iodide symporter gene transfer in wistar rats. Cancer Research, 2004, 64 ( 21 ) : 8045 - 8051.
  • 7Dwyer R M, Bergert E R, O' connor M K, et al. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUCI1 -driven expression of the sodium iodide symporter. Clin Cancer Res, 2005, 11 (4) :1483-1489.
  • 8Inubushi M, Jin Y N, Murai C, et al. Single-photon emission computed tomography of spontaneous liver metastasis from orthotopically implanted human colon cancer cell line stably expressing human sodium/iodide symporter reporter gene. EJNMMI Res, 2012, 2(1) :46.
  • 9Ahn B C. Sodium iodide symporter for nuclear molecular imaging and gene therapy: from bedside to bench and back. Theranostics, 2012, 2(4) :392-402.
  • 10Maxon H R, Thomas S R, Hertzberg V S, et al. Relationship between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med,1983, 309:937-941.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部